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BACKGROUND: Controversy exists regarding the use of 
postoperative antibiotics for nonperforated gangrenous 
appendicitis.
OBJECTIVE: The aim of this study was to evaluate the 
rate of postoperative infectious complications and the 
effect of postoperative antibiotic use among patients with 
nonperforated gangrenous appendicitis.
DESIGN: This was a prospective cohort study conducted 
during 2 months.
SETTINGS: A national multicenter observational study 
was conducted in 62 Dutch hospitals.
PATIENTS: All of the consecutive patients who 
had surgery for suspected acute appendicitis were 
included. Patients were excluded if no appendectomy 
was performed or appendectomy was performed for 
pathology other than acute appendicitis.
MAIN OUTCOMES MEASURES: Type of appendicitis was 
categorized as phlegmonous, gangrenous, or perforated. 
The primary end point was the rate of infectious 
complications (intra-abdominal abscess and surgical 
site infection) within 30 days after appendectomy. 
Univariable and multivariable logistic regression analyses 
were performed to identify predictors of infectious 
complications.
RESULTS: A total of 1863 patients were included: 1321 
(70.9%) with phlegmonous appendicitis, 181 (9.7%) 
with gangrenous appendicitis, and 361 (19.4%) with 
perforated appendicitis. Infectious complications 
were more frequent in patients with gangrenous 
versus phlegmonous appendicitis (7.2% vs 3.8%; p 
= 0.03). This association was no longer statistically 
significant in multivariable analysis (OR = 1.09 (95% 
CI, 0.49–2.44)). There was no significant difference in 
infectious complications between ≤24 hours (n = 57) 
of postoperative antibiotics compared with >24 hours 
(n = 124; 3.6% vs 8.9%; p = 0.35) in patients with 
gangrenous appendicitis.
LIMITATIONS: Possible interobserver variability in the 
intraoperative classification of appendicitis was a study 
limitation.
CONCLUSIONS: Patients with nonperforated 
gangrenous appendicitis are at higher risk of infectious 
complications than patients with phlegmonous 
appendicitis, yet gangrenous disease is not an 
independent risk factor. Postoperative antibiotic 
use over 24 hours was not associated with decreased 
infectious complications. See Video Abstract at http://
links.lww.com/DCR/A1000.
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RESULTADOS POSTOPERATORIOS DE PACIENTES CON 
APENDICITIS GANGRENOSA NO PERFORADA: UN 
ANÁLISIS DE COHORTE PROSPECTIVO MULTICÉNTRICO 
NACIONAL
ANTECEDENTES: Existe controversia sobre el uso 
de antibióticos postoperatorios para la apendicitis 
gangrenosa no perforada.
OBJETIVO: El objetivo de este estudio fue evaluar la tasa 
de complicaciones infecciosas postoperatorias y el efecto 
del uso de antibióticos postoperatorios en pacientes con 
apendicitis gangrenosa no perforada.
DISEÑO: Estudio de cohorte prospectivo realizado 
durante dos meses.
LUGAR: Estudio observacional multicéntrico nacional en 
62 hospitales holandeses.
PACIENTES: Todos los pacientes consecutivos sometidos 
a cirugía por sospecha de apendicitis aguda. Los pacientes 
fueron excluidos si no se realizó una apendicectomía o si 
se realizó una apendicectomía para otra patología que no 
fuera la apendicitis aguda.
PRINCIPALES MEDIDAS DE RESULTADOS: El tipo de 
apendicitis se clasificó como flegmonosa, gangrenosa o 
perforada. El criterio de valoración primario fue la tasa 
de complicaciones infecciosas (absceso intraabdominal 
e infección en el sitio quirúrgico) dentro de los 30 días 
posteriores a la apendicectomía. Se realizaron análisis 
de regresión logística univariables y multivariables para 
identificar predictores de complicaciones infecciosas.
RESULTADOS: Se incluyeron un total de 1863 pacientes: 
1321 (70,9%) con apendicitis flegmonosa, 181 (9,7%) 
con apendicitis gangrenosa y 361 (19,4%) con apendicitis 
perforada. Las complicaciones infecciosas fueron más 
frecuentes en pacientes con apendicitis gangrenosa 
frente a flegmonosa (7,2% frente a 3,8%, p = 0,03). Esta 
asociación ya no fue estadísticamente significativa en el 
análisis multivariable (OR 1,09; IC del 95%: 0,49 a 2,44). 
No hubo diferencias significativas en las complicaciones 
infecciosas entre ≤ 24 h (n = 57) de los antibióticos 
postoperatorios en comparación con> 24 h (n = 124) 
(3,6% vs. 8,9%, p = 0,35) en pacientes con apendicitis 
gangrenosa.
LIMITACIONES: Posible variabilidad interobservador en la 
clasificación intraoperatoria de la apendicitis.
CONCLUSIÓN: Los pacientes con apendicitis gangrenosa 
no perforada tienen un mayor riesgo de complicaciones 
infecciosas que los pacientes con apendicitis flegmonosa, 
aunque la enfermedad gangrenosa no es un factor 
de riesgo independiente. El uso de antibióticos 
postoperatorios durante 24 horas no se asoció con una 
disminución de las complicaciones infecciosas. Vea el 
Resumen del Video en http://links.lww.com/DCR/A1000.
KEY WORDS: Appendectomy; Appendicitis; 
Classification; Postoperative complications.
The treatment of gangrenous nonperforated appen-dicitis is controversial.1,2 Routine administration of postoperative antibiotics to reduce the rate of in-
fectious complications remains a topic of debate. Most 
guidelines lack clear recommendations on gangrenous ap-
pendicitis (GA; gangrenous implies nonperforated gangre-
nous unless specified otherwise).3–7 The guideline by the 
Surgical Infection Society, however, recommends to limit the 
postoperative use of antibiotics to 24 hours.8 Although the 
authors state that this is based on level 1A evidence,8 adher-
ence to the guideline is poor. Many surgeons consider GA as 
a complex appendicitis similar to a perforated appendicitis 
or appendicitis with abscess and/or purulent peritonitis. For 
these patients, antibiotic prophylaxis is usually given for 3 to 
5 postoperative days.7,9,10 On the contrary, others do not pre-
scribe any postoperative antibiotic treatment or just a short 
course (24 or 48 h).9,10 It has been reported in the literature 
that standardization of practice leads to improved surgical 
outcomes for appendicitis and several other indications.11–16 
Therefore, it is key to address this variation in medical care 
and to develop a standardized strategy for this type of ap-
pendicitis. To our knowledge, previous literature focused on 
a population of both phlegmonous appendicitis (PA) and 
GA,17,18 and little is known with respect to merely the latter. 
Therefore, we aimed to evaluate postoperative outcomes for 
gangrenous appendicitis exclusively. The primary aim of this 
study was to compare the rate of postoperative infectious 
complications between patients with GA and PA. Secondly, 
the effect of postoperative antibiotic use on the rate of infec-
tious complications was studied.
PATIENTS AND METHODS
Study Design, Setting, and Participants
In 2014, data from all of the consecutive patients who had 
surgery for suspected acute appendicitis (AA) in 62 Dutch 
hospitals were prospectively collected during a predefined 
2-month study period (June and July). The study protocol 
was reviewed and approved by the medical ethics commit-
tee in the Academic Medical Center in Amsterdam. Owing 
to the observational, noninterventional study design, the 
informed consent requirement was waived. One or 2 sur-
gical residents per participating hospital were responsible 
for the data registration. Additional details on the study 
design can be found in previous publications from this co-
hort.19,20 For this analysis, patients who had an appendec-
tomy (open or laparoscopic) for AA were selected from the 
database. Both adult and pediatric patients were included.
Collected Data
Baseline patient characteristics (ie, sex, age, and ASA classifi-
cation) were registered, as well as several preoperative, intra-
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operative, and postoperative variables, including temperature, 
white blood cell (WBC) count, and C-reactive protein (CRP) 
at presentation; time between onset and operation (hours); 
preoperative antibiotic prophylaxis (yes or no); type of ap-
pendicitis; extent of peritonitis (none, local, or diffuse); type 
(laparoscopic or open) and duration of surgery (in minutes); 
duration of postoperative antibiotic treatment (intravenous 
and oral); overall 30-day postoperative complications; intra-
abdominal abscess (IAA); surgical site infection (SSI); length 
of hospitalization (days from operation); readmission; per-
cutaneous drainage; reoperation; and 30-day mortality.
Outcome Measures
The main outcomes in this study were type of appendi-
citis, duration of postoperative antibiotic use, and rate of 
infectious complications (including IAA and SSI) within 
30 days after appendectomy. The type of appendicitis 
was classified as phlegmonous, gangrenous, or perforated 
based on the operative report. Gangrenous appendicitis 
was defined as appendicitis with signs of necrosis or gan-
grene without mention of macroscopic perforation. Dura-
tion of postoperative antibiotic use was recorded as the total 
duration of intravenous and oral antibiotics together, in 
postoperative days. IAA was defined as a fluid collection 
in the abdomen, diagnosed postoperatively by cross-sec-
tional imaging and necessitating treatment (antibiotics 
treatment or (radiological or surgical) drainage). SSI was 
recorded only if this resulted in restart or prolongation 
of antibiotic treatment or surgical drainage of the wound 
(under local or generalized anesthesia). Secondary out-
comes were length of hospital stay (LOS) and the rate of o-
verall complications, readmission, percutaneous drainage, 
and/or reoperation (all within 30 d after appendectomy).
Statistical Analysis
In univariable analysis, outcomes were compared between 
gangrenous and other types of appendicitis. The independ-
ent samples Student t test and Mann–Whitney test were used 
in case of continuous variables, and the χ2 and Fisher exact 
test were used in case of categorical variables, as appropriate. 
To evaluate the effect of duration of postoperative antibiotic 
treatment on the infectious complication rate, groups of dif-
ferent duration were compared with the same statistical tests 
as described for the primary end point. Furthermore, logis-
tic regression analysis was performed to compare outcomes 
in multivariable analysis. A 2-sided p < 0.05 was considered 
significant. All of the data analysis was performed in SPSS 
version 21 (IBM Corp, Armonk, NY). This article was writ-
ten using the Strengthening the Reporting of Observational 
Studies in Epidemiology statement checklist.21
RESULTS
In June and July 2014, 1975 patients had surgery for 
suspected AA. The details of these patients have been 
 described in previous reports.19,20 After exclusion of 112 
patients (Fig. 1), 1863 remained eligible for analysis. The 
median age was 29 years (interquartile range (IQR), 16–
47), and 514 (27.6%) were under the age of 18 years. Fifty-
three percent (980/1863) were male. Type of appendicitis 
was scored as phlegmonous in 1321 (70.9%), gangrenous 
in 181 (9.7%), and perforated in 361 patients (19.4%). In 
total, there were 237 postoperative complications (12.7%), 
and 137 (7.4%) were infectious complications. The rate of 
infectious complications was 20.5% in patients with per-
forated appendicitis versus 7.2% in patients with GA and 
3.8% in patients with PA (p < 0.001). Patients with perfo-
rated disease were excluded from additional analyses.
PA Versus GA
Significant differences in baseline and perioperative char-
acteristics were observed between patients with GA and PA. 
Patients with GA had a higher median (IQR) age (40 (19–56) 
vs 27 y (16–42); p < 0.001) and had higher WBC count and 
CRP levels at presentation (Table 1). Postoperative antibiot-
ics were administered significantly more often to patients 
All patients undergoing surgery for suspected
AA in original snapshot database (N = 1975)
All patients with AA (N = 1911)
Normal appendix (N = 60)
Malignnant appendix (N = 4)
Patients excluded (N = 48):
-   Inflammatory mass, no resection (N = 5)
-   Hemicolectomy (N = 2)
-   Ileocecal resection (N = 3)
-   Iatrogenic perforation (N = 38)
Final patients selection (N = 1863)
FIGURE 1. Patients included in present analysis. AA = acute appendicitis.
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with GA versus those with PA (74.6% vs 9.7%; p < 0.001). 
The rate of infectious complications was significantly higher 
among patients with GA compared with PA (7.2% vs 3.8%; 
p = 0.033), as were the rates of IAA and complications over-
all (Table 2). In addition, median (IQR) LOS was 3 days (2–5 
d) for GA compared with 2 days (1–2 d) for PA (p < 0.001).
Risk Factors for Infectious Complications
In univariable analysis, risk factors for the development 
of an infectious complication in patients with GA and PA 
included increasing age, elevated temperature at presen-
tation, higher level of WBCs at presentation, presence of 
localized or diffuse peritonitis (versus none), and gan-
grenous disease (versus phlegmonous). In multivariable 
logistic regression analysis, only age, WBC count, and du-
ration of surgery showed a statistically significant associa-
tion with infectious complications (Table 3).
Postoperative Antibiotics for GA
Among 181 patients with GA, postoperative antibiotic use 
was limited to ≤24 hours in 57 patients (31.5%) and given 
>24 hours in 124 patients (68.5%). Patients with extended 
antibiotic use were older (median age = 44 (IQR, 24–59 y) 
vs 31 y (IQR, 13–59 y); p = 0.006), had higher median CRP 
levels at presentation (78 (IQR, 29–144 mg/L) vs 46 mg/L 
(IQR, 17–86 mg/L); p = 0.003), and more frequently showed 
local or diffuse peritonitis during surgery (14% vs 57.3%; p < 
0.001). Infectious complications occurred more often among 
patients with extended antibiotic use, but the difference was 
not statistically significant (3.5% vs 8.9%; p = 0.233; Table 4). 
The median LOS was prolonged by the extended antibiotic 
use (4 (IQR, 3–6) vs 2 d (IQR, 1–2); p < 0.001).
DISCUSSION
This prospective cohort study demonstrated that patients 
with nonperforated GA are at higher risk of postoperative 
TABLE 1.   Baseline and perioperative characteristics of the study population (N = 1502)
Variable GA (n = 181) PA (n = 1321) p
Age, median (IQR), y 40 (19–56) 27 (16–42) <0.001
Sex, male, n (%) 103 (56.9) 687 (52) 0.216
ASA, n (%)   0.076 (f )
  I–II 173 (95.6) 1292 (97.8)  
  III–IV 8 (4.4) 29 (2.2)  
Temperature, mean (SD), °C 37.6 (0.8) 37.3 (0.7) <0.001
WBC, mean (SD), 109/L 15 (4.7) 13.7 (4.6) <0.001
CRP, median (IQR), mg/L 64 (26–124) 24 (9–54) <0.001
Time to surgery, median (IQR), h 6.5 (4–14) 6.5 (4–13) 0.331
Preoperative AB prophylaxis, n (%) 175 (96.7) 1260 (95.4) 0.426
Type of surgery, n (%)   0.954
  Laparoscopic 133 (73.5) 968 (73.3)  
  Open 48 (26.5)a 353 (26.7)b  
Degree of peritonitis, n (%)   <0.001
  None 102 (56.4) 1216 (92.1)  
  Localized 67 (37) 91 (6.9)  
  Diffuse 12 (6.6) 14 (1.1)  
Duration of surgery, median (IQR), min 44 (32–56) 38 (30–50) <0.001
Postoperative AB use, n (%) 135 (74.6) 128 (9.7) <0.001
Duration postoperative AB use, n (%)   <0.001
  None 46 (25.4) 1192 (90.2)  
  24 h 11 (6.1) 33 (2.5))  
  2–3 d 37 (20.4) 28 (2.1)  
  4–5 d 64 (35.4) 48 (3.7)  
  >5 d 23 (12.7) 19 (1.4)  
PA = phlegmonous appendicitis; GA = gangrenous appendicitis; IQR = interquartile range; f = Fisher exact test; WBC = white blood cell count; CRP = C-reactive protein; AB, 
antibiotics.
aA total of 7 gangrenous appendicitis patients (3.8%) had laparoscopy converted to open surgery.
bA total of 15 phlegmonous appendicitis patients (1.1%) had laparoscopy converted to open surgery.
TABLE 2.   Univariable outcome analysis (N = 1502)
Variable GA (n = 181) PA (n = 1321) p
LOS, median (IQR), d 3 (2–5) 2 (1–2) <0.001
Any complication, n (%) 31 (17.1) 101 (7.6) <0.001
Infectious complication, n (%) 13 (7.2) 50 (3.8)a 0.033
  IAA 11 (6.1) 23 (1.7) 0.001
  SSI 2 (1.1) 32 (2.4) 0.421 (f )
Readmission, n (%) 11 (6.1) 56 (4.2) 0.261
Reintervention, n (%) 6 (3.3)b 20 (1.5)c 0.117 (f )
  Percutaneous drainage 4 (2.2) 15 (1.1) 0.273 (f )
  Reoperation 4 (2.2) 14 (1.1) 0.260
Mortality, n (%) 1 (0.6) 1 (0.08) 0.227
LOS = length of stay; PA = phlegmonous appendicitis; GA = gangrenous appendici-
tis; IAA = intra-abdominal abscess; SSI = surgical site infection; f = Fisher exact test.
aFive patients experienced IAA and SSI.
bTwo patients underwent drainage and reoperation. 
cNine patients underwent drainage and reoperation.
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infectious complications than patients with PA. However, 
having GA (versus PA) was not identified as an independ-
ent risk factor for developing infectious complications. 
Postoperative antibiotic use longer than 24 hours after ap-
pendectomy was not associated with a decreased rate of 
infectious complications but did correlate with a longer 
length of stay.
Patients with GA were shown to differ from patients 
with PA on various levels. They are older, they have higher 
CRP and WBC levels at arrival to the hospital, and they 
present with localized or diffuse peritonitis in the abdo-
men more often than patients with PA. The rate of intra-
abdominal abscess was >3 times as high in patients with 
GA compared with patients with PA. This confirms in a 
multicenter prospective setting what was previously re-
ported by Romano et al22 in their retrospective single-
center study including 372 patients. In this study, age, 
WBC count, and duration of surgery were identified as 
independent risk factors for infectious complications, 
whereas a gangrenous type of appendicitis was not. A pre-
vious study on nonperforated appendicitis (n = 728) by 
Coakley et al17 identified open surgery and GA (both the 
surgical and histopathologic assessments) as risk factors. 
Only patients with a histopathologic confirmation of non-
perforated appendicitis were included in their study, and 
the rate of infectious complications observed was 8.4% 
(61/728). In contrast, the rate in this study was 4.2%, 63 
infectious complications among 1502 patients, whereas 
inclusion was solely based on the intraoperative classifica-
tion appendicitis. Open surgery showed a slight trend to-
ward significance, which might reflect a type II error here. 
Had the study population or the infectious complication 
rate been larger, a significant association with infectious 
complications might have arisen.
As expected, the majority of patients with GA re-
ceived antibiotics postoperatively, whereas 25% were not 
given any antibiotics after appendectomy. If the surgeon 
chose to prescribe postoperative antibiotic treatment, this 
lasted >24 hours in 92% of the patients. This did not de-
crease the infectious complications rate when comparing 
patients with 24 hours of postoperative antibiotics versus 
none. However, LOS was longer in patients with extended 
antibiotic use: the median LOS was doubled compared 
with patients who received a maximum of 24 hours of 
treatment. This finding is consistent with the results from 
a small cohort study (n = 58) by Emil et al.1 They reported 
an almost 50% reduction in LOS without an increase in 
complications for patients with GA given 2 postoperative 
doses of antibiotics instead of the conventional longer 
treatment duration based on clinical criteria.1 This further 
supports the recommended duration of 24 hours of post-
operative antibiotics in the Surgical Infection Society/In-
fectious Diseases Society of America guideline, currently 
based on only 1 study on nonperforated appendicitis by 
Mui et al.18 In this randomized controlled trial, prolonged 
antibiotic use was associated with an increase of complica-
tions related to antibiotic treatment without a reduction 
of infectious complications. This is in line with a recent 
single-center (n = 1007) study by Nordin et al23 as well. 
The authors reported outcomes before and after a proto-
col change toward classifying GA as simple appendicitis 
and omitting postoperative antibiotics.23 A significant de-
crease in hospitalization and antibiotic use was observed 
for patients with gangrenous disease (n = 69), without an 
increase in complications.
TABLE 3.   Multivariable outcome analysis, n=1502
Variable
Univariable analysis Multivariable analysis
OR 95% CI p OR 95% CI p
Age, y 1.01 1.00–1.03 0.04 1.02 1.00–1.03 0.046
Temperature, ˚C 1.51 1.08–2.10 0.015 1.32 0.91–1.91 0.146
WBC, 109/L 1.06 1.01–1.12 0.016 1.07 1.00–1.13 0.038
CRP, mg/L 1.00 0.99–1.01 0.100 1.00 0.99–1.00 0.470
Peritonitis (vs none) 1.93 1.03–3.62 0.042 1.28 0.55–2.94 0.567
GA (vs PA) 1.97 1.05–3.69 0.036 0.88 0.37–2.10 0.768
Open procedure (vs laparoscopic) 1.50 0.88–2.55 0.135 1.68 0.89–3.14 0.107
Duration of surgery, min 1.02 1.01–1.03 0.006 1.02 1.01–1.04 0.004
Postoperative AB use (vs none) 2.29 1.32–3.95 0.003 1.55 0.65–3.69 0.318
WBC = white blood cell count; CRP = C-reactive protein; GA = gangrenous appendicitis; PA = phlegmonous appendicitis; AB, antibiotic.
TABLE 4.   Postoperative antibiotics for gangrenous appendicitis 
(N = 181)
Variable
≤24 h  
(n = 57)
> 24 h  
(n = 124) p
LOS, median (IQR), d 2 (1–2) 4 (3–6) <0.001
Any complication, n (%) 4 (7.0) 27 (21.8) 0.014
 Infectious complication, n (%) 2 (3.5) 11 (8.9) 0.233
  IAA, n (%) 2 (3.5) 9 (7.3) 0.506 (f )
  SSI, n (%) – 2 (1.6) 1.0 (f )
Readmission, n (%) 4 (7.0) 7 (5.6) 0.743 (f )
Reintervention, n (%) 1 (1.8) 5 (4) 0.667 (f )
  Percutaneous 
  drainage, n (%)
1 (1.8) 3 (2.4) 1.0 (f )
  Reoperation, n (%) 1 (1.8) 3 (2.4) 1.0 (f )
Mortality, n (%) – 1 (0.8) 1.0 (f )
LOS = length of stay; IQR = interquartile range; IAA = intra-abdominal abscess; SSI = 
surgical site infection.
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In clinical practice and research, PA is usually clas-
sified as simple appendicitis, whereas GA and perforated 
appendicitis are most often categorized together as com-
plex appendicitis. This study emphasizes that these 3 types 
of appendicitis have different risks of infectious complica-
tions: 3.8%, 7.2%, and 20.5%. This implies that GA should 
perhaps be considered a separate entity, instead of being 
categorized together with either PA or perforated appen-
dicitis. GA was more often accompanied by localized or 
diffuse pus than PA (37% vs 7%). Although the degree of 
peritonitis was not proven to be an independent risk fac-
tor for infectious complications in the present analysis, it 
is likely that this does play a role to some extent. Previ-
ous studies have reported a correlation between peritoni-
tis and postoperative complications.24,25 Therefore, apart 
from the aspect of the appendix, the degree of peritonitis 
should perhaps also be part of the classification system.26 
Surgeons are already familiar with using this in their de-
cision regarding whether to prescribe postoperative anti-
biotics.9,10 The optimum classification of appendicitis that 
correlates well with clinical outcomes has yet to be devel-
oped.27,28 This may help the standardization of practice in 
the future.
Strengths and Limitations
The strengths of the present study are the prospective na-
ture, national study participation, and the large number 
of patients included. Nonetheless, some important limita-
tions need to be mentioned. First of all, patient inclusion 
in this study was based on the intraoperative classification 
of appendicitis by surgeons. This surgical classification is 
known to be more predictive of postoperative outcomes 
than the histopathologic classification,29 but it is also asso-
ciated with interobserver variability, and its reliability may 
therefore be questioned.10,30 This concerns the distinction 
between perforated and nonperforated appendicitis, as 
well as assessment of gangrenous discoloration. Moreo-
ver, (assessment of) the extent of necrosis may vary: an 
appendix could show phlegmonous inflammation for the 
greater part with necrosis at the tip. This may be differently 
classified and treated depending on the surgeon operating, 
which may in turn have influenced results. Second, con-
cerning the analysis of postoperative antibiotic use, one 
may argue that some bias may be present, because patients 
at higher risk of complications may have been prescribed 
more antibiotics than the more fit patients.
Despite its limitations, this study shows that patients 
with nonperforated GA differ from patients with PA in 
baseline characteristics and risk of postoperative infec-
tious complications. Nonperforated GA should be consid-
ered its own distinctive entity, separate from phlegmonous 
(simple) and perforated (complex) appendicitis. Future 
research should focus on a universal and reliable classi-
fication system for appendicitis and a standardization of 
postoperative antimicrobial policy.
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